CTLA4 and cancer: Immune exhaustion marker genes (such as PD-L1, CTLA-4, LAG-3 and HAVCR2) have been demonstrated to play significant role in immune suppression in multiple tumors and several target inhibitors have also been widely applied to immunotherapy for cancers [37].